Unraveling the complexity of vitamin B12 diseases
Nature Communications study has implications for treatment of patients and genetic counselling
RI-MUHC researchers led one of Québec Science magazine’s top 10 discoveries of the year
Jean-Jacques Lebrun and his team have discovered a promising treatment for triple negative breast cancer
Three RI-MUHC research projects funded in special CIHR calls
Projects will mitigate impacts of the COVID-19 pandemic on children, youth and families and promote vaccine confidence
$2M to the MUHC Foundation for precision cancer care
BMO gift will help cancer researchers at the RI-MUHC develop the hospital’s precision oncology program
McGill team’s index predicts coma recovery with 100% accuracy
New Adaptive Reconfiguration Index has crucial implications for clinical management and decision-making in unconscious and unresponsive...
FANCI: a new gene at the origin of some cases of ovarian cancer
For the first time, researchers link mutations in the FANCI gene to the risk of developing ovarian cancer
RI-MUHC trainee Prisca Bustamante honoured by Mitacs Award for Outstanding Innovation
Doctoral student develops world's first non-invasive blood screening test for uveal melanoma
Adel Schwertani is corecipient of the sixth Tomoh Masaki Award
RI-MUHC scientist receives international acclaim for research that benefits pulmonary arterial hypertension patients
RI-MUHC study shows impact of combinatorial immunotherapy on an aggressive cancer
A combinatorial immunotherapy may provide significant therapeutic benefit in managing pancreatic ductal...
RI-MUHC team studies a novel, fully automated insulin delivery system
A new publication in Lancet Digital Health describes an important step that may improve glucose control and quality of life for people with type 1...